NSC 740 |
||
---|---|---|
Data | Docs | Dec2010 2D structures - 2D chemical structure coordinates |
Data | Docs | Sept2014 2D structures - 2D chemical structure coordinates |
Data | Docs | 2D chemical structure - 2D chemical structure coordinates |
Data | Docs | 3D chemical structure - 3D chemical structure coordinates |
Data | Docs | SMILES - SMILES string representation of chemical structure |
Data | Docs | molecular formula - Molecular Formula |
Data | Docs | molecular weight - Molecular Weight |
Data | Docs | chemical name - Trivial and systematic chemical names in the NCI/DIS |
Data | Docs | NCI 6day Cancer Screen 08/2002 - DTP 60 cell/5dose/6day-Aug 2002 |
Docs | DTP OneDose/Three Cell Synth - DTP One Dose/Three cell line Synthetic Compound Cancer Screen | |
Data | NCI AIDS Screen Current Data - DTP AIDS-04/2004 release | |
Data | Docs | NCI Cancer Screen 10/2009 Data - DTP 60 cell/5 dose-10/2009 |
Docs | OneDose/Syn/60 Cell 10/2009 - DTP One Dose/Sixty cell line Cancer Screen Against Synthetic Compounds | |
Docs | NCI60 dose response 02/2010 - NCI 60 cell line screen dose response data-02/2010 | |
Data | Docs | NCI Cancer Screen 12/2010 Data - DTP 60 cell/5 dose-12/2010 |
Docs | OneDose/Syn/60 Cell 12/2010 - DTP One Dose/Sixty cell line Cancer Screen Against Synthetic Compounds 12/2010 | |
Docs | NCI60 dose response 12/2010 - NCI 60 cell line screen dose response data-12/2010 | |
Data | Docs | NCI Cancer Screen 03/2012 Data - DTP 60 cell/5 dose-03/2012 |
Docs | OneDose/Syn/60 Cell 03/2012 - DTP One Dose/Sixty cell line Cancer Screen Against Synthetic Compounds 03/2012 | |
Docs | NCI60 dose response 03/2012 - NCI 60 cell line screen dose response data-03/2012 | |
Data | Docs | NCI Cancer Screen 08/2012 Data - DTP 60 cell/5 dose-08/2012 |
Docs | OneDose/Syn/60 Cell 08/2012 - DTP One Dose/Sixty cell line Cancer Screen Against Synthetic Compounds 08/2012 | |
Docs | NCI60 dose response 08/2012 - NCI 60 cell line screen dose response data-08/2012 | |
Data | Docs | NCI Cancer Screen 09/2014 Data - DTP 60 cell/5 dose-09/2014 |
Docs | OneDose/Syn/60 Cell 09/2014 - DTP One Dose/Sixty cell line Cancer Screen Against Synthetic Compounds 09/2014 | |
Docs | NCI60 dose response 09/2014 - NCI 60 cell line screen dose response data-09/2014 | |
Data | Docs | NCI Cancer Screen Current Data - DTP 60 cell/5 dose-06/2016 |
Data | Docs | DTP OneDose/Syn/60 Cell Line - DTP One Dose/Sixty cell line Cancer Screen Against Synthetic Compounds 06/2016 |
Data | Docs | NCI60 dose response - NCI 60 cell line screen dose response data-06/2016 |
Data | Docs | Stage 0 Yeast Screen Data - Stage 0 results from the NCI Seattle yeast anticancer drug screen |
Data | Docs | Stage 1 Yeast Screen Data - Stage 1 results from the NCI Seattle yeast anticancer drug screen |
Data | Docs | Stage 2 Yeast Screen Data - Stage 2 results from the NCI Seattle yeast anticancer drug screen |
Data | Docs | NCI C/EBPα I
- Assay type: cell based reporter Plate format: 384 well Target: C/EBPα Library: NCI Training Set Concentration: 1.0 µM |
Data | Docs | NCI HIF-1 I
- Assay type: cell based reporter Plate format: 384 well Target: HIF-1 Library: NCI Training Set Concentration: 1.0 µM |
Data | Docs | NCI Met Screen II
- Assay type: cell based Plate format: 384 well Target: Met HGF/SF Library: NCI Training Set Concentration: 1.0 µM |
Data | Docs | Tumor 16 (sc) in 1A - C3H Mammary Adenocarcinoma 16/C (subcutaneous) in B6C3F1 mice |
Data | Docs | Tumor 25 (sc) in 08 - Carcinoma 1025 (subcutaneous) in C3AKF1 (CHKRF1) mice |
Data | Docs | Tumor 28 (ip) in 02 - P288 Lymphocytic Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor 2R (ip) in 06 - P388 Leukemia resistant to Tiazofurin; NSC 286193, Developed at LMCB,DTP,DCT,NCI (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor 2T (ip) in 02 - P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 06 & 41 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor 2T (ip) in 06 - P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 06 & 41 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor 2U (ip) in 02 - P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 01 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor 2X (ip) in 03 - P288 Lymphocytic Leukemia resistant to methotrexate; NSC 740 (intraperitoneal) in C57BL/6 mice |
Data | Docs | Tumor 2X (ip) in 06 - P288 Lymphocytic Leukemia resistant to methotrexate; NSC 740 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor 49 (sc) in 08 - L4946 Lymphatic Leukemia (Solid) (subcutaneous) in C3AKF1 (CHKRF1) mice |
Data | Docs | Tumor 4A (sc) in 08 - L4946 Lymphatic Leukemia resistant to Azaserine; NSC 742 (subcutaneous) in C3AKF1 (CHKRF1) mice |
Data | Docs | Tumor 5P (ip) in 02 - P335 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor 6T (ip) in 02 - L1210 Leukemia resistant to 6-Thioguanine; NSC 752 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor 6T (ip) in 06 - L1210 Leukemia resistant to 6-Thioguanine; NSC 752 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor 7P (sc) in 03 - CA 755 resistant to 6-Mercaptopurine; NSC 755 (subcutaneous) in C57BL/6 mice |
Data | Docs | Tumor 81 (ip) in 02 - P1081 Chloroleukemia (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor 8C (sc) in 09 - P1798 resistant to Cortisone; NSC 9703 (subcutaneous) in unknown mice |
Data | Docs | Tumor 8P (sc) in 09 - P1798 Lymphosarcoma (subcutaneous) in unknown mice |
Data | Docs | Tumor 91 (sc) in 02 - S-91 Cloudman Melanotic Melanoma (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor 98 (ip) in 02 - C1498 Myeloid Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor A2 (sc) in 09 - ADJ-PC-20 Plasma Cell (subcutaneous) in unknown mice |
Data | Docs | Tumor A3 (ip) in 09 - Lieberman Plasma Cell No. 1 (LPC-1) (intraperitoneal) in unknown mice |
Data | Docs | Tumor A3 (ip) in 22 - Lieberman Plasma Cell No. 1 (LPC-1) (intraperitoneal) in CAF1 mice |
Data | Docs | Tumor A5 (sc) in 09 - ADJ-PC-5 Plasma Cell (subcutaneous) in unknown mice |
Data | Docs | Tumor A6 (ip) in 06 - ADJ-PC-6 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor A6 (ip) in 28 - ADJ-PC-6 (intraperitoneal) in BALB/cJ mice |
Data | Docs | Tumor AA in 02 - Nontumored Animals (Toxicity Test) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor AA in 06 - Nontumored Animals (Toxicity Test) in CD2F1 (CDF1) mice |
Data | Docs | Tumor AD (sc) in 09 - ADJ-PC-22 Plasma Cell (subcutaneous) in unknown mice |
Data | Docs | Tumor AK (ip) in 18 - Lymphoma AKR (Transplanted) (intraperitoneal) in AKR/Lw mice |
Data | Docs | Tumor B1 (ip) in 02 - B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor B1 (sc) in 02 - B16 Melanoma (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor B1 (im) in 02 - B16 Melanoma (intramuscular) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor B1 (ic) in 02 - B16 Melanoma (intracerebral) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor B1 (ip) in 03 - B16 Melanoma (intraperitoneal) in C57BL/6 mice |
Data | Docs | Tumor B1 (ip) in 1A - B16 Melanoma (intraperitoneal) in B6C3F1 mice |
Data | Docs | Tumor BC (sc) in 02 - L1210 Leukemia resistant to BCNU; NSC 409962 (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor C2 (SRC) in 1D - HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice |
Data | Docs | Tumor C2 (SRC) in 1F - HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor C6 (ip) in 06 - Colon 26 Adenocarcinoma (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor C8 (sc) in 02 - Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor C8 (im) in 02 - Colon Carcinoma 38 (intramuscular) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor C8 (sc) in 1A - Colon Carcinoma 38 (subcutaneous) in B6C3F1 mice |
Data | Docs | Tumor C9 (sc) in 1D - CX-5 Colon Xenograft (subcutaneous) in NU/NU Swiss (nude) mice |
Data | Docs | Tumor C9 (SRC) in 1D - CX-5 Colon Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice |
Data | Docs | Tumor CA (sc) in 02 - Adenocarcinoma 755 (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor CA (sc) in 03 - Adenocarcinoma 755 (subcutaneous) in C57BL/6 mice |
Data | Docs | Tumor CD (sc) in 49 - Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1 |
Data | Docs | Tumor CL (ip) in 1F - NCI-H460 Large Cell Carcinoma of the Lung (intraperitoneal) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor CL (SRC) in 1F - NCI-H460 Large Cell Carcinoma of the Lung (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor EM (ic) in 03 - Ependymoblastoma (intracerebral) in C57BL/6 mice |
Data | Docs | Tumor EP (ic) in 1A - Ependymoblastoma (intracerebral) in B6C3F1 mice |
Data | Docs | Tumor FR (ip) in 02 - P815 resistant to 5-Fluorouridine; NSC 27640 (Ascitic) (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor FU (ip) in 02 - P815 resistant to 5-Fluorouracil; NSC 19893 (Ascitic) (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor FV (sc) in 02 - Friend Virus Leukemia (Solid) (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor GA (ip) in 07 - Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3H/He mice |
Data | Docs | Tumor GA (ip) in 08 - Lymphosarcoma Gardner 6C3HED (intraperitoneal) in C3AKF1 (CHKRF1) mice |
Data | Docs | Tumor HE (sc) in 07 - Cystadenocarcinoma, Liver (No. 1) (Hamster) (subcutaneous) in C3H/He mice |
Data | Docs | Tumor JA (SRC) in 1F - NCI-H23 Human Lung Adenocarcinoma (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JC (SRC) in 1F - NCI-H522 Human Lung Adenocarcinoma (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JD (SRC) in 1F - NCI-H125 Human Lung Adenosquamous Carcinoma (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JE (SRC) in 1F - NCI-H358 Human Lung Bronchiolo-Alveolar Carcinoma (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JG (SRC) in 1F - NCI-H520 Human Lung Squamous Cell Carcinoma (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JH (SRC) in 1F - NCI-H-69 Human Lung "Classic" SCLC (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JK (SRC) in 1F - NCI-H82 Human Lung "Variant" SCLC (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JM (sc) in 1F - LOVO Human Colon Tumor (subcutaneous) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JP (sc) in 1F - DLD-1 Human Colon Tumor (subcutaneous) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JV (SRC) in 1F - DU145 Human Prostate Tumor (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JX (sc) in 1F - OVCAR-5 Human Ovarian Tumor (subcutaneous) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor JZ (sc) in 1F - SK-MES-1 Non Small Cell Lung (Squamous Cell) (subcutaneous) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor K4 (ip) in 08 - AK4 Lymphoid Leukemia (intraperitoneal) in C3AKF1 (CHKRF1) mice |
Data | Docs | Tumor KD (SRC) in 1F - MCF-7-Breast Adenocarcinoma/ADR resistant (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor L8 (ip) in 02 - Lymphoma 8 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor L8 (ip) in 06 - Lymphoma 8 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor L9 (ip) in 06 - L5178Y Lymphatic Leukemia resistant to L-Asparaginase; NSC 109229 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LB (ip) in 02 - L1210 Leukemia resistant to BIC; NSC 82196 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LC (ip) in 02 - L1210 Leukemia resistant to Cytosine Arabinoside; NSC 63878 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LC (ip) in 06 - L1210 Leukemia resistant to Cytosine Arabinoside; NSC 63878 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LD (ip) in 02 - L1210 Leukemia resistant to DTIC; NSC 45388 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LE (ip) in 02 - L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LE (sc) in 02 - L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LE (ic) in 02 - L1210 Leukemia (intracerebral) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LE (iv) in 02 - L1210 Leukemia (intravenous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LE (sc) in 04 - L1210 Leukemia (subcutaneous) in DBA/2 mice |
Data | Docs | Tumor LE (ip) in 05 - L1210 Leukemia (intraperitoneal) in BCF1 mice |
Data | Docs | Tumor LE (ip) in 06 - L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LE (sc) in 06 - L1210 Leukemia (subcutaneous) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LE (ic) in 06 - L1210 Leukemia (intracerebral) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LF (sc) in 02 - L1210 Leukemia resistant to Methotrexate & Dichloromethotrexate; NSC 740, NSC 29630 (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LF (ip) in 06 - L1210 Leukemia resistant to Methotrexate & Dichloromethotrexate; NSC 740, NSC 29630 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LF (sc) in 06 - L1210 Leukemia resistant to Methotrexate & Dichloromethotrexate; NSC 740, NSC 29630 (subcutaneous) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LH (ip) in 02 - L1210 Leukemia resistant to Cyclocytidine; NSC 145668 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LK (SRC) in 1D - Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice |
Data | Docs | Tumor LK (SRC) in 1F - Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor LL (sc) in 02 - Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LL (im) in 02 - Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LL (iv) in 02 - Lewis Lung Carcinoma (intravenous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LL (it) in 02 - Lewis Lung Carcinoma (intrathoracic) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LL (sc) in 03 - Lewis Lung Carcinoma (subcutaneous) in C57BL/6 mice |
Data | Docs | Tumor LL (im) in 03 - Lewis Lung Carcinoma (intramuscular) in C57BL/6 mice |
Data | Docs | Tumor LL (iv) in 1A - Lewis Lung Carcinoma (intravenous) in B6C3F1 mice |
Data | Docs | Tumor LM (ip) in 06 - L1210 Leukemia resistant to Dichloromethotrexate; NSC 29630 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LM (sc) in 06 - L1210 Leukemia resistant to Dichloromethotrexate; NSC 29630 (subcutaneous) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LN (SRC) in 1F - A549 Human Adenocarcinoma of Lung with characteristics of Type II Alveolar Epithelial cells (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor LO (ip) in 1F - Human Amelanotic Melanoma (LOX) (intraperitoneal) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor LO (SRC) in 1F - Human Amelanotic Melanoma (LOX) (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor LV (SRC) in 1F - NCI-H322 Human Lung Bronchiolo-Alveolar Carcinoma (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor LW (ip) in 02 - L1210 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LX (ip) in 02 - L1210 Leukemia resistant to Methotrexate; NSC 740 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LX (sc) in 02 - L1210 Leukemia resistant to Methotrexate; NSC 740 (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor LX (ip) in 06 - L1210 Leukemia resistant to Methotrexate; NSC 740 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor LX (sc) in 06 - L1210 Leukemia resistant to Methotrexate; NSC 740 (subcutaneous) in CD2F1 (CDF1) mice |
Data | Docs | Tumor M2 (sc) in 09 - MPC-2 Plasma Cell (subcutaneous) in unknown mice |
Data | Docs | Tumor M5 (ip) in 02 - Sarcoma M5076 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor M5 (sc) in 02 - Sarcoma M5076 (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor M5 (ip) in 1A - Sarcoma M5076 (intraperitoneal) in B6C3F1 mice |
Data | Docs | Tumor MB (SRC) in 1D - Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice |
Data | Docs | Tumor MB (SRC) in 1F - Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor MD (im) in 09 - Madison 109 Lung Carcinoma (intramuscular) in unknown mice |
Data | Docs | Tumor MF (sc) in 1D - Human Breast MX-2 Xenograft (subcutaneous) in NU/NU Swiss (nude) mice |
Data | Docs | Tumor ML (sc) in 02 - L1210 Leukemia resistant to Methyl-GAG; NSC 32946 (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor MP (ip) in 02 - L1210 Leukemia resistant to 6-MP & 6-Thioguanine; NSC 755, NSC 752 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor MP (sc) in 02 - L1210 Leukemia resistant to 6-MP & 6-Thioguanine; NSC 755, NSC 752 (subcutaneous) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor MP (ip) in 06 - L1210 Leukemia resistant to 6-MP & 6-Thioguanine; NSC 755, NSC 752 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor MP (ic) in 06 - L1210 Leukemia resistant to 6-MP & 6-Thioguanine; NSC 755, NSC 752 (intracerebral) in CD2F1 (CDF1) mice |
Data | Docs | Tumor MY (iv) in 1G - Myeloid Leukemia in RFM/UN Mouse (intravenous) in RMF/UN mice |
Data | Docs | Tumor OS (sc) in 07 - Osteogenic Sarcoma HE 10734 (subcutaneous) in C3H/He mice |
Data | Docs | Tumor P3 (ip) in 06 - P1534 resistant to Methotrexate; NSC 740 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor P4 (ip) in 02 - P1534 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor P4 (ip) in 06 - P1534 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor P6 (ip) in 06 - P388 Leukemia resistant to L-Alanosine; NSC 153353 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor P7 (ip) in 02 - P388 Leukemia resistant to Methotrexate; NSC 740 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor P7 (ip) in 06 - P388 Leukemia resistant to Methotrexate; NSC 740 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor P9 (ip) in 02 - P329 Reticulum Cell Sarcoma (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor P9 (ip) in 04 - P329 Reticulum Cell Sarcoma (intraperitoneal) in DBA/2 mice |
Data | Docs | Tumor PA (ip) in 06 - P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 08 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor PE (ip) in 06 - P388 Leukemia resistant to AMSA; NSC 249992 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor PF (ip) in 06 - P388 Leukemia resistant to Dihydroxy Anthracenedione; NSC 299195 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor PK (ip) in 06 - P388 Leukemia resistant to Ellipticine; NSC 71795 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor PS (ip) in 02 - P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor PS (ic) in 02 - P388 Leukemia (intracerebral) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor PS (ip) in 06 - P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor PS (ic) in 06 - P388 Leukemia (intracerebral) in CD2F1 (CDF1) mice |
Data | Docs | Tumor PV (ip) in 02 - P388 Leukemia resistant to Vincristine; NSC 67574 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor PV (ip) in 06 - P388 Leukemia resistant to Vincristine; NSC 67574 (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor PW (ip) in 02 - P388 Leukemia resistant to A Terephthalanilide; NSC 38280 (intraperitoneal) in B6D2F1 (BDF1) mice |
Data | Docs | Tumor PY (sc) in 39 - PY89 Sarcoma (subcutaneous) in mice (species not specified) |
Data | Docs | Tumor RS (ip) in 06 - Reticulum Cell Sarcoma (Kelley Mouse) (intraperitoneal) in CD2F1 (CDF1) mice |
Data | Docs | Tumor SA (sc) in 01 - Sarcoma 180 (subcutaneous) in Swiss mice |
Data | Docs | Tumor TE (SRC) in 1F - TE-671 Human Meduloblastoma (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor UG (SRC) in 1F - U-251 Human Glioma (intrarenal inoculation) in NU/NU BALB/C (nude) mice |
Data | Docs | Tumor VA (sc) in 1D - Colon Xenograft CS-1 (subcutaneous) in NU/NU Swiss (nude) mice |
Data | Docs | Tumor VB (sc) in 1D - Colon Xenograft CS-2 (subcutaneous) in NU/NU Swiss (nude) mice |
Data | Docs | Tumor VR (sc) in 1D - Melanoma Xenograft MS-6 (subcutaneous) in NU/NU Swiss (nude) mice |